I had a meeting with some public health center staff the other day.It was to prepare for a study session on swallowing for ...

Shionogi’s IntraBio acquisition brings Aqneursa, a drug approved for treating two rare neurological disorders and the potential to expand to additional indications, both rare and common. It’s Shionogi ...

A new meta-analysis of eight randomized controlled trials finds that mindfulness-based interventions may improve cognitive ...

Researchers from Kennedy Krieger Institute, University of Rochester Medicine and five other institutions released a new ...

Neurological disorders are disorders that affect the central nervous system or the peripheral nervous systems and can impair the brain, spinal cord, peripheral nerve or neuromuscular function.

When the aging brain misfires, the results can be astonishing and a little alarming.

Recently published Parkinson's Disease Market Insights report includes a comprehensive understanding of current treatment practices, Parkinson's disease emerging drugs, market share of individual ...

The family of a 13-year-old boy from Long Beach is asking for help as he remains hospitalized with a rare disease linked to ...

Alector grants Genentech exclusive rights to develop and commercialize AL050, an investigational GCase Enzyme Replacement Therapy (ERT) enabled ...

Today, 24 organizations, representing communities in rare disease, oncology, autoimmune and inflammatory conditions, ...

A survey of 159 frontline health workers in rural and conflict-affected Cameroon reveals severe gaps in neurological ...